Biofunctional Surface Engineering

1. Auflage 2014
ISBN: 978-981-4411-60-8
Verlag: Pan Stanford Publishing

Buch, Englisch, 344 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 602 g

Successful biofunctional surface engineering will determine the future of medical devices such as orthopedic implants, stents, catheters, vaccine scaffolds, wound dressings, and extracorporeal circulation devices. Moreover, the biosensor and diagnostic chip technology will evolve rapidly due to the growing medical need for personalized medicine. A major drawback in these technologies is the need for terminally sterilized products. However, novel and safe technologies, including coupling, stabilization, and protection of effector molecules, enable terminal sterilization without functional loss. This book provides a comprehensive overview on the state of the art and the future of biofunctional surface engineering and is of major interest for those working in the fields of medicine and medical devices.

Zielgruppe

Academic and Postgraduate

Autoren/Hrsg.

Scholz, Martin

Fachgebiete

• Naturwissenschaften Biowissenschaften Angewandte Biologie Biophysik
• Naturwissenschaften Physik Thermodynamik Oberflächen- und Grenzflächenphysik, Dünne Schichten
• Naturwissenschaften Physik Angewandte Physik Biophysik
• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Technologie der Oberflächenbeschichtung
• Technische Wissenschaften Maschinenbau | Werkstoffkunde Technische Mechanik | Werkstoffkunde Materialwissenschaft: Biomaterialien, Nanomaterialien, Kohlenstoff

Inhaltsverzeichnis

Regulatory Issues. Sterilization of Combination Devices. Polyelectrolyte Monolayers (I). Polyelectrolyte Monolayers (II). Surface Modifications. Three Dimensional Characterization of Immobilized Biomolecules. Aptamers for Biofunctionalization of Stents. Coating of Implants with Antibiotics. Microneedles and Nanopatches for Vaccination. Microchips for Antibody Binding Analyses. Biofunctionalized Wound Dressings. Extracorporeal Device for Trapping Circulating Tumor Cells. Outlook.

Über Autor(innen)

Martin Scholz is a biologist and an expert in the biological functionalization of materials. As chief scientific officer with LEUKOCARE, a Germany-based biotech company, he is responsible for the company’s R&D activities regarding biologic-device combination products with focus on improved biomolecule stability during stress exposure such as irradiation and long-term product storage. Prof. Scholz’s track record shows more than 25 years of academic and industrial research activities in the field of biology and medical research.